Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Crawl-delay: 10 Allow: / User-agent: Eluta.ca Crawl-delay: 60 Allow: / User-agent: MS Search 6.0 Robot Crawl-delay: 60 Allow: / User-agent: gsa-crawler Crawl-delay: 60 Allow: |
Title | Reata Pharmaceuticals Inc. - |
Description | Changing the landscape inLife-Threatening Twitter opens in a new window Linkedin opens in a new window Facebook opens in a new window Instagram opens in a new window Site Search Search query About |
Keywords | N/A |
WebSite | reatapharma.com |
Host IP | 162.159.129.11 |
Location | United States |
Site | Rank |
US$29,261,606
Last updated: 2023-05-07 07:34:27
reatapharma.com has Semrush global rank of 361,713. reatapharma.com has an estimated worth of US$ 29,261,606, based on its estimated Ads revenue. reatapharma.com receives approximately 3,376,340 unique visitors each day. Its web server is located in United States, with IP address 162.159.129.11. According to SiteAdvisor, reatapharma.com is safe to visit. |
Purchase/Sale Value | US$29,261,606 |
Daily Ads Revenue | US$27,011 |
Monthly Ads Revenue | US$810,322 |
Yearly Ads Revenue | US$9,723,857 |
Daily Unique Visitors | 225,090 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
reatapharma.com. | A | 599 | IP: 162.159.129.11 |
reatapharma.com. | NS | 3600 | NS Record: pdns12.domaincontrol.com. |
reatapharma.com. | NS | 3600 | NS Record: pdns11.domaincontrol.com. |
reatapharma.com. | MX | 1800 | MX Record: 0 reatapharma-com.mail.protection.outlook.com. |
reatapharma.com. | TXT | 1800 | TXT Record: v=spf1 ip4:38.142.36.154 ip4:71.78.249.90 ip4:206.123.103.196 ip4:107.20.210.250 ip4:52.1.14.157 ip4:135.84.68.123 ip4:47.190.106.76 ip4:70.125.254.170 ip4:18.206.193.5 ip4:100.26.80.169 ip4:3.228.157.248 ip4:23.21.202.37 ip4:54.243.188.124 ip4:3.14.169.2 32 ip4:3.128.47.132 ip4:3.136.57.202 ip4:68.171.172.82 ip4:50.31.46.70 include:spf.protection.outlook.com include:mailsenders.netsuite.com include:mail.zendesk.com include:mail1.wpengine.com -all |
reatapharma.com. | TXT | 1800 | TXT Record: BB2D-9F9C-56DD-3184-0542-A69C-08DF-E992 |
reatapharma.com. | TXT | 1800 | TXT Record: google-site-verification=ZFCBklI1L2lSj7VZQL52OAh2R0uDvXGs3W-XZ-KBX6w |
reatapharma.com. | TXT | 1800 | TXT Record: 2598-1D17-3D1F-A2B5-ACF1-AAFB-4A00-035A |
reatapharma.com. | TXT | 1800 | TXT Record: google-site-verification=Xd2cFd0tDdjbA-QpkjDTmY3DPy2VkYNzsZLKZYwfAdI |
reatapharma.com. | TXT | 1800 | TXT Record: v=verifydomain MS=3990590 |
reatapharma.com. | TXT | 1800 | TXT Record: v=verifydomain MS=6759045 |
reatapharma.com. | TXT | 1800 | TXT Record: v=verifydomain MS=8270984 |
reatapharma.com. | TXT | 1800 | TXT Record: MS=ms61989140 |
reatapharma.com. | TXT | 1800 | TXT Record: 0ed1fe018abe9920bd233f46478715f5c073b96489 |
reatapharma.com. | TXT | 1800 | TXT Record: v=verifydomain MS=7460502 |
reatapharma.com. | TXT | 1800 | TXT Record: v=verifydomain MS=4656961 |
reatapharma.com. | TXT | 1800 | TXT Record: docusign=8e0932a2-12d7-4dff-9c75-032c883d1c8d |
reatapharma.com. | TXT | 1800 | TXT Record: apple-domain-verification=ZC9FmLp1614Id5cC |
reatapharma.com. | TXT | 1800 | TXT Record: smartsheet-site-validation=JwTqCM9ySAOcOp5vBbPek8wzYYKA7_g0 |
reatapharma.com. | TXT | 1800 | TXT Record: utckJ2RYDjyY7kdmmGu4iGWFsuQAM9Lfxr8R7lY2/zBMCm+X3VAmkV7vG6SMowAE0Xrrl6uM/X7bdhRkzNO0/Q== |
Twitter opens in a new window Linkedin opens in a new window Facebook opens in a new window Instagram opens in a new window Site Search Search query About Us What we do Who we are Leadership Ethics & Compliance California Declaration Grants & Sponsorships Independent Medical Educational Grants Submitting an application Sponsorships Submitting an application Our Science Our Technologies Nrf2 Activators Bardoxolone Methyl HSP90 Modulators Pipeline Partnering & In-Licensing Diseases We Target Neurology Friedreich’s Ataxia Diabetic Peripheral Neuropathic Pain Chronic Kidney Disease ADPKD Alport Syndrome Product Prescribing Information Our Community Patient Advocacy Clinical Trials Early Access Investors Overview Stock Information Stock Quote Stock Chart Historical Stock Quote Investment Calculator Analyst Coverage News Events & Presentations Financials Quarterly Results Annual Reports SEC Filings ESG ESG Overview Environmental Social Governance Documents & Charters Committee Composition |
HTTP/1.1 301 Moved Permanently Date: Wed, 27 Oct 2021 15:04:20 GMT Content-Type: text/html; charset=utf-8 Connection: keep-alive Location: https://reatapharma.com/ CF-Ray: 6a4cd0f7ec002c2c-ORD CF-Cache-Status: HIT Expect-CT: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" X-Content-Type-Options: nosniff Set-Cookie: __cf_bm=2DYicv.Viyqu1aHIVSqhp75laRwAfXsHZjBEj7gqjfE-1635347060-0-AWiGAwdPG3beP3h3YJKHFcs+D8BGzOUHir1PZ24D9Bj/A7D8zvqEyGz5lGE8slHk1cAv1sdHIQbxnGfxxefn/zw=; path=/; expires=Wed, 27-Oct-21 15:34:20 GMT; domain=.reatapharma.com; HttpOnly; SameSite=None Server: cloudflare HTTP/2 301 date: Wed, 27 Oct 2021 15:04:20 GMT content-type: text/html; charset=utf-8 location: /home/default.aspx cf-ray: 6a4cd0f8ffdd2bb3-ORD cache-control: public, max-age=120, stale-if-error=86400, stale-while-revalidate=86400 strict-transport-security: max-age=3600 cf-cache-status: EXPIRED expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" x-content-type-options: nosniff x-xss-protection: 0 set-cookie: __cf_bm=f2HkvpnWOr5sEYgPGoYbJcqCoI7xSLGGN_hNp7tAaCU-1635347060-0-Ab4zXyatyJgCf4P1KgsEbXRtSeDEby1rrd/JdpnwQP8uIrKZA1DeQv/SYYY6K/fJ8aQ9+8WsRM7w2lmCx4aDTh8=; path=/; expires=Wed, 27-Oct-21 15:34:20 GMT; domain=.reatapharma.com; HttpOnly; Secure; SameSite=None server: cloudflare HTTP/2 200 date: Wed, 27 Oct 2021 15:04:20 GMT content-type: text/html; charset=utf-8 cf-ray: 6a4cd0fa09b22bb3-ORD cache-control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400 strict-transport-security: max-age=3600 vary: Accept-Encoding cf-cache-status: REVALIDATED expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" x-content-type-options: nosniff x-xss-protection: 0 set-cookie: __cf_bm=bbPTirc95X7HqChQybPEcF3ygjiiRDnOC4MjyvNgRO0-1635347060-0-AVyGrHdDOI3xpYWl5skT2QC2sgH7BoBSVtnFeljtoO3ICMZHvwSuN4Dgm8A6dmA7zZuM+xR3TR3bnDgV/iYHp9c=; path=/; expires=Wed, 27-Oct-21 15:34:20 GMT; domain=.reatapharma.com; HttpOnly; Secure; SameSite=None server: cloudflare |
Domain Name: REATAPHARMA.COM Registry Domain ID: 139632788_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-01-13T15:02:37Z Creation Date: 2005-01-14T19:06:18Z Registry Expiry Date: 2023-01-14T19:06:18Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: PDNS11.DOMAINCONTROL.COM Name Server: PDNS12.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-15T11:38:06Z <<< |